Establishment Labs Holdings Inc. Stock

Equities

ESTA

VGG312491084

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 10:15:38 2024-05-17 am EDT 5-day change 1st Jan Change
58.78 USD +1.41% Intraday chart for Establishment Labs Holdings Inc. +4.99% +126.92%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 180M Sales 2025 * 243M Capitalization 1.59B
Net income 2024 * -50M Net income 2025 * -22M EV / Sales 2024 * 9.93 x
Net Debt 2024 * 200M Net Debt 2025 * 208M EV / Sales 2025 * 7.4 x
P/E ratio 2024 *
-32.1 x
P/E ratio 2025 *
-73.3 x
Employees 908
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.83%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Establishment Labs Holdings Inc., Q1 2024 Earnings Call, May 08, 2024
Establishment Labs Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Posts Q1 Revenue $37.2M, vs. Street Est of $35.5M MT
Establishment Labs Holdings Inc. Provides Revenue Guidance for the Year 2024 CI
Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating MT
Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility MT
Mizuho Securities Raiset Price Target on Establishment Labs to $65 From $50, Keeps Buy Rating MT
TD Cowen Adjusts Establishment Labs Price Target to $60 From $50, Maintains Outperform Rating MT
Transcript : Establishment Labs Holdings Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 02:30 PM
Transcript : Establishment Labs Holdings Inc., Q4 2023 Earnings Call, Feb 28, 2024
Establishment Labs Holdings Inc. Provides Revenue Guidance for the Year 2024 CI
Establishment Labs Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (ESTA) ESTABLISHMENT LABS HOLDINGS Reports Q4 Revenue $31.6M, vs. Street Est of $31.6M MT
Establishment Labs Announces Amended Credit Facility with Oaktree CI
Establishment Labs Holdings Inc. announced that it has received $49.999102 million in funding CI
More news

Latest transcript on Establishment Labs Holdings Inc.

1 day+1.41%
1 week+4.99%
Current month+17.48%
1 month+12.66%
3 months+56.25%
6 months+167.05%
Current year+126.92%
More quotes
1 week
55.35
Extreme 55.35
60.12
1 month
44.86
Extreme 44.86
60.12
Current year
24.42
Extreme 24.42
60.12
1 year
16.96
Extreme 16.96
73.00
3 years
16.96
Extreme 16.96
93.80
5 years
7.56
Extreme 7.56
93.80
10 years
7.56
Extreme 7.56
93.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 12-12-31
Director of Finance/CFO 54 21-02-23
Chief Tech/Sci/R&D Officer 44 08-12-31
Members of the board TitleAgeSince
Director/Board Member 75 17-11-30
Director/Board Member 72 15-07-31
Chairman 46 15-08-31
More insiders
Date Price Change Volume
24-05-17 58.75 +1.36% 10 086
24-05-16 57.96 -3.17% 216,934
24-05-15 59.86 +1.79% 223,842
24-05-14 58.81 +4.66% 304,373
24-05-13 56.19 +0.41% 221,824

Delayed Quote Nasdaq, May 17, 2024 at 09:59 am EDT

More quotes
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
57.96 USD
Average target price
63 USD
Spread / Average Target
+8.70%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW